N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I:
1
Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-&agr; expression utilizing compounds of the present invention are also disclosed.
抑制 p38 激酶从而阻断细胞因子产生的 N-杂环化合物已被披露。在一种实施例中,本发明的化合物由式 I 表示。还披露了利用本发明化合物的生产方法、药物组合物以及治疗与不当 p38 激酶活性或 TNF-α 表达相关的疾病的方法。
N- heterocyclic inhibitors of TNF-alpha expression
申请人:——
公开号:US20020137747A1
公开(公告)日:2002-09-26
N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I:
1
Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-&agr; expression utilizing compounds of the present invention are also disclosed.
[EN] N-HETEROCYCLIC INHIBITORS OF TNF-ALPHA EXPRESSION<br/>[FR] INHIBITEURS N-HETEROCYCLIQUES DE L'EXPRESSION DE TNF-ALPHA
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2003002542A1
公开(公告)日:2003-01-09
N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula (I). Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-a expression utilizing compounds of the present invention are also disclosed.
[EN] CYTOKINE, ESPECIALLY TNF-ALPHA, INHIBITORS<br/>[FR] INHIBITEURS DE LA CYTOKINE, EN PARTICULIER DE TNF-ALPHA
申请人:PHARMACOPEIA INC
公开号:WO2001047897A1
公开(公告)日:2001-07-05
N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I. Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-α expression utilizing compounds of the present invention are also disclosed.
METHOD FOR PRODUCING DYE POLYMER, DYE POLYMER AND USE OF THE SAME
申请人:Shimanaka Hiroyuki
公开号:US20110112242A1
公开(公告)日:2011-05-12
Disclosed are a production process of a dye polymer having a dye content of from 1 to 50 wt %, and the dye polymer and its use. The production process includes subjecting an addition-polymerizable monomer to living radical polymerization by using, as a polymerization initiator, a dye having a polymerization initiating group enabling the living radical polymerization. The dye polymer and a composition of the dye polymer and a pigment are useful as good coloring agents for various products or articles. The colored products or articles are high in transparency, and are provided with high added value. The dye polymer can also be used as a dispersant for pigments, thereby making it possible to afford pigment dispersions excellent in dispersion properties and dispersion stability.